Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-24 Purchase |
2025-02-26 7:21 pm |
ARDELYX INC. | ARDX | MOTT DAVID M Director |
77,729 | $5.0012 | $388,738 | 2,015,494 (Direct) |
View |
| 2025-01-21 Purchase |
2025-01-22 5:25 pm |
ARDELYX INC. | ARDX | MOTT DAVID M Director |
199,000 | $4.9883 | $992,672 | 1,937,765 (Direct) |
View |
| 2024-12-19 Purchase |
2024-12-23 5:59 pm |
ARDELYX INC. | ARDX | MOTT DAVID M Director |
213,300 | $4.6722 | $996,580 | 1,638,765 (Direct) |
View |
| 2024-11-13 Purchase |
2024-11-14 4:26 pm |
ARDELYX INC. | ARDX | MOTT DAVID M Director |
215,868 | $4.6167 | $996,598 | 1,425,465 (Direct) |
View |
| 2022-11-17 Purchase |
2022-11-17 4:07 pm |
ARDELYX INC. | ARDX | MOTT DAVID M Director |
567,000 | $1.7648 | $1,000,642 | 1,166,765 (Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 6:59 pm |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
8,994 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2022-02-18 Purchase |
2022-02-23 7:12 pm |
IMARA Inc. | IMRA | MOTT DAVID M Director |
151,472 | $1.4502 | $219,667 | 229,224 (Direct) |
View |
| 2022-02-15 Purchase |
2022-02-17 7:21 pm |
IMARA Inc. | IMRA | MOTT DAVID M Director |
45,926 | $1.1905 | $54,673 | 77,752 (Direct) |
View |
| 2022-02-10 Purchase |
2022-02-14 5:02 pm |
IMARA Inc. | IMRA | MOTT DAVID M Director |
31,826 | $1.2331 | $39,246 | 31,826 (Direct) |
View |
| 2021-09-23 Sale |
2021-09-24 5:10 pm |
NOVAVAX INC | NVAX | MOTT DAVID M Director |
24,961 | $252.9 | $6,312,616 | 40,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-26 Exercise |
2024-12-27 5:57 pm |
N/A N/A |
ARDELYX INC. | ARDX | MOTT DAVID M Director |
100,000 | $0.55 | 1,738,765 (Direct) |
View |
| 2024-12-26 Exercise |
2024-12-27 5:57 pm |
N/A 2032-06-15 |
ARDELYX INC. | ARDX | MOTT DAVID M Director |
100,000 | $0 | 1,738,765 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-01 5:04 pm |
2025-07-01 2034-07-01 |
Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director |
1,583,214 | $0 | 1,583,214 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-17 6:47 pm |
N/A 2034-06-14 |
ARDELYX INC. | ARDX | MOTT DAVID M Director |
57,565 | $0 | 1,249,840 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-14 4:06 pm |
2024-06-12 2033-06-12 |
NOVAVAX INC | NVAX | MOTT DAVID M Director |
6,670 | $0 | 76,520 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:06 pm |
2025-06-12 2034-06-12 |
NOVAVAX INC | NVAX | MOTT DAVID M Director |
15,630 | $15.86 | 76,520 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:06 pm |
2025-06-12 2034-06-12 |
NOVAVAX INC | NVAX | MOTT DAVID M Director |
10,420 | $0 | 76,520 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-12 4:53 pm |
N/A 2034-06-10 |
Mersana Therapeutics Inc. | MRSN | MOTT DAVID M Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:11 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | MOTT DAVID M Director |
8,810 | $0 | 598,289 (Direct) |
View |
| 2023-10-02 Option Award |
2023-10-04 4:26 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | MOTT DAVID M Director |
15,873 | $0 | 589,479 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-06 4:18 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | MOTT DAVID M Director |
6,079 | $0 | 573,606 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-03 5:01 pm |
2024-07-03 2033-07-03 |
Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director |
1,462,927 | $0 | 1,462,927 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 6:29 pm |
N/A 2033-06-15 |
ARDELYX INC. | ARDX | MOTT DAVID M Director |
74,747 | $0 | 1,241,512 (Direct) |
View |
| 2023-06-10 Exercise |
2023-06-13 4:47 pm |
N/A N/A |
NOVAVAX INC | NVAX | MOTT DAVID M Director |
3,100 | $0 | 58,180 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-13 4:47 pm |
2024-06-12 2033-06-12 |
NOVAVAX INC | NVAX | MOTT DAVID M Director |
14,380 | $0 | 58,180 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:15 pm |
N/A 2033-06-07 |
Mersana Therapeutics Inc. | MRSN | MOTT DAVID M Director |
32,822 | $0 | 585,882 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 5:14 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | MOTT DAVID M Director |
4,866 | $0 | 553,060 (Direct) |
View |
| 2022-08-12 Equity Swap |
2022-08-16 6:59 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
322,453 | $0 | 0 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:06 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
16,156 | $1.47 | 331,447 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 5:00 pm |
2023-07-01 2032-07-01 |
Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director |
1,000,439 | $0 | 1,000,439 (Direct) |
View |
| 2022-06-17 Exercise |
2022-06-21 8:49 pm |
N/A N/A |
NOVAVAX INC | NVAX | MOTT DAVID M Director |
700 | $0 | 40,700 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-21 4:51 pm |
N/A 2032-06-15 |
ARDELYX INC. | ARDX | MOTT DAVID M Director |
282,481 | $0 | 699,765 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:09 pm |
2023-06-10 2032-06-10 |
NOVAVAX INC | NVAX | MOTT DAVID M Director |
7,700 | $0 | 7,700 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:19 pm |
N/A 2032-06-08 |
Mersana Therapeutics Inc. | MRSN | MOTT DAVID M Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 8:17 pm |
N/A 2032-06-01 |
IMARA Inc. | IMRA | MOTT DAVID M Director |
8,500 | $0 | 237,724 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:26 pm |
N/A 2032-05-16 |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
50,000 | $0 | 356,297 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 5:30 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
20,653 | $1.15 | 306,297 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:07 pm |
N/A 2032-01-02 |
Mersana Therapeutics Inc. | MRSN | MOTT DAVID M Director |
18,518 | $0 | 18,518 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:20 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
9,500 | $2.5 | 285,644 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-01 4:30 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
4,640 | $5.12 | 276,144 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:01 pm |
2022-07-01 2031-07-01 |
Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director |
579,494 | $0 | 579,494 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-01 4:15 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
2,858 | $8.31 | 271,504 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 5:29 pm |
N/A 2031-06-28 |
IMARA Inc. | IMRA | MOTT DAVID M Director |
7,728 | $0 | 7,728 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 5:20 pm |
2022-06-17 2031-06-17 |
NOVAVAX INC | NVAX | MOTT DAVID M Director |
2,000 | $0 | 2,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:07 pm |
N/A 2031-06-16 |
ARDELYX INC. | ARDX | MOTT DAVID M Director |
32,765 | $0 | 32,765 (Direct) |
View |